Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 197

1.

How I treat ALK-positive non-small cell lung cancer.

McCusker MG, Russo A, Scilla KA, Mehra R, Rolfo C.

ESMO Open. 2019 Jul 20;4(Suppl 2):e000524. doi: 10.1136/esmoopen-2019-000524. eCollection 2019. Review.

2.

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study.

Singhal S, Rolfo C, Maksymiuk AW, Tappia PS, Sitar DS, Russo A, Akhtar PS, Khatun N, Rahnuma P, Rashiduzzaman A, Ahmed Bux R, Huang G, Ramjiawan B.

Cancers (Basel). 2019 Jul 29;11(8). pii: E1069. doi: 10.3390/cancers11081069.

3.

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.

Banerji U, van Herpen CML, Saura C, Thistlethwaite F, Lord S, Moreno V, Macpherson IR, Boni V, Rolfo C, de Vries EGE, Rottey S, Geenen J, Eskens F, Gil-Martin M, Mommers EC, Koper NP, Aftimos P.

Lancet Oncol. 2019 Aug;20(8):1124-1135. doi: 10.1016/S1470-2045(19)30328-6. Epub 2019 Jun 27.

PMID:
31257177
4.

Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Are We Ready for the Combination?

McCusker MG, Scilla KA, Simone CB 2nd, Sachdeva A, Miller KD, Burke AP, Rolfo C.

J Thorac Oncol. 2019 Jun 21. pii: S1556-0864(19)30379-X. doi: 10.1016/j.jtho.2019.05.013. [Epub ahead of print] No abstract available.

PMID:
31235402
5.

Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis.

Tahtamouni L, Ahram M, Koblinski J, Rolfo C.

Anal Cell Pathol (Amst). 2019 May 14;2019:1356508. doi: 10.1155/2019/1356508. eCollection 2019. No abstract available.

6.

The Role of Circulating Tumor DNA in Lung Cancer: Mutational Analysis, Diagnosis, and Surveillance Now and into the Future.

Scilla KA, Rolfo C.

Curr Treat Options Oncol. 2019 Jun 15;20(7):61. doi: 10.1007/s11864-019-0653-2. Review.

PMID:
31203467
7.

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

Signorelli D, Giannatempo P, Grazia G, Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V, Pisapia P, Cona MS, Rolfo C, Malapelle U, Group IY.

Biomed Res Int. 2019 Apr 24;2019:9056417. doi: 10.1155/2019/9056417. eCollection 2019. Review.

8.

Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line.

Van Der Steen N, Leonetti A, Keller K, Dekker H, Funel N, Lardon F, Ruijtenbeek R, Tiseo M, Rolfo C, Pauwels P, Peters GJ, Giovannetti E.

Biochem Pharmacol. 2019 Aug;166:128-138. doi: 10.1016/j.bcp.2019.05.014. Epub 2019 May 10.

PMID:
31078602
9.

Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules.

Ren Y, Huang S, Dai C, Xie D, Zheng L, Xie H, Zheng H, She Y, Zhou F, Wang Y, Li P, Fei K, Jiang G, Zhang Y, Su B, Sweet-Cordero EA, Tran NL, Yang Y, Patel JN, Rolfo C, Rocco G, Cardona AF, Tuzi A, Suter MB, Yang P, Xu W, Chen C.

Front Oncol. 2019 Apr 18;9:288. doi: 10.3389/fonc.2019.00288. eCollection 2019.

10.

Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life).

Biolè C, Huczek Z, Nuñez-Gil I, Boccuzzi G, Autelli M, Montefusco A, Trabattoni D, Ryan N, Venuti G, Imori Y, Takano H, Matsuda J, Shimizu W, Muscoli S, Montabone A, Wojakowski W, Rognoni A, Helft G, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Pennone M, Mattesini A, Templin C, Quadri G, Wańha W, Cerrato E, Smolka G, Protasiewicz M, Kuliczkowski W, Rolfo C, Cortese B, Capodanno D, Chieffo A, Morbiducci U, Iannaccone M, Gili S, di Mario C, D'Amico M, Romeo F, Lüscher TF, Sheiban I, Escaned J, Varbella F, D'Ascenzo F.

Int J Cardiol. 2019 Sep 1;290:64-69. doi: 10.1016/j.ijcard.2019.03.038. Epub 2019 Mar 22.

PMID:
30971372
11.

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.

Sorber L, Zwaenepoel K, Jacobs J, De Winne K, Goethals S, Reclusa P, Van Casteren K, Augustus E, Lardon F, Roeyen G, Peeters M, Van Meerbeeck J, Rolfo C, Pauwels P.

Cancers (Basel). 2019 Mar 30;11(4). pii: E458. doi: 10.3390/cancers11040458.

12.

Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor.

Soza-Ried C, Bustamante E, Caglevic C, Rolfo C, Sirera R, Marsiglia H.

Crit Rev Oncol Hematol. 2019 Jul;139:128-133. doi: 10.1016/j.critrevonc.2019.01.012. Epub 2019 Jan 25. Review.

PMID:
30878179
13.

Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.

Rolfo C, de Vos-Geelen J, Isambert N, Molife LR, Schellens JHM, De Grève J, Dirix L, Grundtvig-Sørensen P, Jerusalem G, Leunen K, Mau-Sørensen M, Plummer R, Learoyd M, Bannister W, Fielding A, Ravaud A.

Clin Pharmacokinet. 2019 Mar 16. doi: 10.1007/s40262-019-00754-4. [Epub ahead of print]

PMID:
30877569
14.

Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study).

D'Ascenzo F, Omedè P, De Filippo O, Cerrato E, Autelli M, Trabattoni D, Ryan N, Venuti G, Muscoli S, Montabone A, Wojakowski W, Rognoni A, Helft G, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Boccuzzi G, Mattesini A, Wańha W, Smolka G, Huczek Z, Cortese B, Sheiban I, Escaned J, Biolè C, Conrotto F, Templin C, Quadri G, Rolfo C, Capodanno D, Chieffo A, Nuñez-Gil I, Morbiducci U, Iannaccone M, Gili S, Mario CD, Moretti C, D'Amico M, Varbella F, Romeo F, Lüscher TF.

Am J Cardiol. 2019 May 15;123(10):1610-1619. doi: 10.1016/j.amjcard.2019.02.013. Epub 2019 Feb 23.

PMID:
30846212
15.

Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trial.

Malapelle U, Raez LE, Serrano MJ, Rolfo C; International Society of Liquid Biopsies (ISLB).

J Thorac Dis. 2018 Dec;10(12):6388-6391. doi: 10.21037/jtd.2018.11.22. No abstract available.

16.

Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.

Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ.

Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0.

17.

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network.

Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Miguel ME, Jang JH, Martin-Uriz PS, Castro-Labrador L, Vilas-Zornoza A, Lara-Astiaso D, Ponz-Sarvise M, Rolfo C, Santos ES, Raez LE, Taverna S, Behrens C, Weder W, Wistuba II, Vicent S, Gil-Bazo I.

Cancer Res. 2019 Feb 1;79(3):625-638. doi: 10.1158/0008-5472.CAN-18-1479. Epub 2018 Dec 18.

PMID:
30563891
18.

Immunotherapy in Lung Cancer: A New Age in Cancer Treatment.

Corrales L, Scilla K, Caglevic C, Miller K, Oliveira J, Rolfo C.

Adv Exp Med Biol. 2018;995:65-95. doi: 10.1007/978-3-030-02505-2_3. Review.

PMID:
30539506
19.

The value of immunotherapy in head and neck cancer.

Manca P, Raez LE, Salzberg M, Sanchez J, Hunis B, Rolfo C.

Expert Opin Biol Ther. 2019 Jan;19(1):35-43. doi: 10.1080/14712598.2019.1556637. Epub 2018 Dec 20. Review.

PMID:
30537444
20.

Spontaneous coronary artery dissection treated with magnesium-made bioresorbable scaffold: 1-Year angiographic and optical coherence tomography follow-up.

Quadri G, Cerrato E, Rolfo C, Varbella F.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E130-E133. doi: 10.1002/ccd.27971. Epub 2018 Nov 12.

PMID:
30419604

Supplemental Content

Loading ...
Support Center